Cargando…

Tumor-infiltrating IL-17A(+) cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer

The role of IL-17A(+) cells remains controversial among various cancer types. This study aimed to investigate the effects of IL-17A(+) cells on tumor immune contexture and clinical outcome in muscle-invasive bladder cancer (MIBC). In this study, we enrolled 141 patients from Zhongshan Hospital, 118...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zewei, Zhou, Quan, Zeng, Han, Zhang, Hongyu, Liu, Zhaopei, Huang, Qiuren, Xiong, Ying, Wang, Jiajun, Chang, Yuan, Bai, Qi, Xia, Yu, Wang, Yiwei, Zhu, Yu, Xu, Le, Dai, Bo, Liu, Li, Guo, Jianming, Xu, Jiejie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153847/ https://www.ncbi.nlm.nih.gov/pubmed/32313725 http://dx.doi.org/10.1080/2162402X.2020.1747332

Ejemplares similares

Intratumoral CCR5(+) neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses
por: Xiang, Zhuoyi, et al.
Publicado: (2020)

Stromal LAG-3(+) cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture
por: Zeng, Han, et al.
Publicado: (2020)

Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin(+) cell abundance
por: Zhou, Quan, et al.
Publicado: (2020)

Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients
por: Xiong, Ying, et al.
Publicado: (2020)

Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer
por: Liu, Zhaopei, et al.
Publicado: (2020)

NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
por: Yan, Sen, et al.
Publicado: (2022)

Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5(+) CD8(+) T cell abundance
por: Huang, Qiuren, et al.
Publicado: (2020)

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma
por: Zhou, Quan, et al.
Publicado: (2020)

Tumor-infiltrating TNFRSF9(+) CD8(+) T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response
por: Li, Yaohui, et al.
Publicado: (2020)

Tumor‐infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer
por: Wang, Jie, et al.
Publicado: (2018)

Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients
por: Liu, Chunnan, et al.
Publicado: (2022)

Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer
por: Xu, Yijia, et al.
Publicado: (2022)

Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
por: Dai, Siyuan, et al.
Publicado: (2021)

Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
por: Bo, Xiaobo, et al.
Publicado: (2018)

Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
por: Li, Wandi, et al.
Publicado: (2023)

Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2017)

Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022)

High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
por: Xi, Wei, et al.
Publicado: (2016)

Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2017)

High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients
por: Fu, Hangcheng, et al.
Publicado: (2016)

Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2015)

Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression
por: Xu, Xianglai, et al.
Publicado: (2023)

A rare case of acute promyelocytic leukemia with ider(17)(q10)t(15;17)(q22;q21) and favorable outcome
por: Liu, Yongming, et al.
Publicado: (2020)

VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
por: Zhang, Mi, et al.
Publicado: (2022)

CD103(+) tumor-infiltrating lymphocytes predict favorable prognosis in patients with esophageal squamous cell carcinoma
por: Chu, Yifan, et al.
Publicado: (2019)

Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2017)

Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
por: Wang, Jiajun, et al.
Publicado: (2017)

B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients
por: Xie, Huyang, et al.
Publicado: (2018)

Expression of IL-23R and IL-17 and the pathology and prognosis of urinary bladder carcinoma
por: Liu, Jian, et al.
Publicado: (2018)

Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer
por: Yang, Xihua, et al.
Publicado: (2018)

Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2016)

Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
por: Xia, Yu, et al.
Publicado: (2017)

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma
por: Wang, Zewei, et al.
Publicado: (2016)

Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivo
por: WANG, DEGUI, et al.
Publicado: (2013)

Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer
por: Xia, Qi-Dong, et al.
Publicado: (2022)

ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC
por: Yang, Zhenlin, et al.
Publicado: (2021)

Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma
por: Bo, Xiaobo, et al.
Publicado: (2017)

Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2016)

Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2016)

High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gaebg0sujj5nv911p0kktgf3l1